Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131808) titled 'Building an Artificial Intelligence Model for Prostate Cancer Prediction Based on Multimodal Data' on Sept. 7.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Peking Union Medical College Hospital

Condition: Prostate carcinoma

Intervention: Gold Standard:Biopsy pathology

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-08-01

Target Sample Size: Target condition:100;Difficult condition:100

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=286043

Published by HT Digital Content Servi...